Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 16/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22848405 | 0.86 | RAPGEF4 (0.60) | RAPGEF4ALDH1A1HPGDHSD17B10 | |
| SCHEMBL18134975 | 0.81 | HPGD (0.53) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL19533724 | 0.80 | ALDH1A1 (0.59) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL22848481 | 0.78 | RAPGEF4 (0.68) | RAPGEF4CYP1A2CYP2A6 | |
| SCHEMBL19763110 | 0.77 | CDC25B (0.49) | CYP1A2ALDH1A1HPGDHSD17B10KDM1A | |
| SCHEMBL24029998 | 0.77 | ALDH1A1 (0.67) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL22848171 | 0.77 | ALDH1A1 (0.52) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL28194328 | 0.77 | CYP1A2 (0.53) | RAPGEF4CYP1A2CYP2A6ALDH1A1HPGD | |
| SCHEMBL23765045 | 0.75 | ALDH1A1 (0.59) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL16657696 | 0.75 | ALDH1A1 (0.70) | CYP2A6ALDH1A1HPGDHSD17B10MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, CRY2, CCNE2 | RAPGEF4 3624/4885CYP1A2 1346/4885CYP2A6 2286/4885 |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | RAPGEF4 3624/4885CYP1A2 1346/4885CYP2A6 2286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.